Company intelligence / Profile preview

Oisín Biotechnologies

Seattle, Washington, United Statesoisinbio.com ↗
Ownership
Private
Development stage
Other
01

Overview

Preclinical data published showing significant increases in muscle mass (+50%) and strength (+100%) in animal models using follistatin gene therapy delivered by PLV. Demonstrated clearance of senescent cells leading to lifespan extension (>20% increase in median lifespan in aged mice). The PLV platform has passed Phase II human trials as a COVID vaccine delivery system, supporting safety[3][5][9].

Therapeutic areas
OtherNephrology
Modalities
Genetic medicines / gene therapyDNA and RNA therapeutics delivered via proprietary nonviral delivery systemSenolytic therapies targeting senescent cellsTherapies targeting muscle growth and adipocyte elimination
Industry
Biotech
02

Drug pipeline

2 assets

OB-001

Unknown

1 more asset in the full pipeline.

03

Partnerships

Licensing relationship with Entos Pharmaceuticals for Fusogenix PLV platformAbbVie Ventures is a lead investor and board participant following Series A financing[3][7].

Beyond the preview

Go deeper on Oisín Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oisín Biotechnologies.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call